MAY 2007
FEATURE STORY
Over
the next two decades, Las Vegas may just become the world’s
best place to grow old. Nevada-based nonprofit Keep
Memory Alive, led by Larry Ruvo, is building the Lou Ruvo
Brain Institute (LRBI), the planet’s most comprehensive
research and treatment facility for Alzheimer’s and
other brain aging diseases.
LRBI’s CEO Dr. Zaven
Khachaturian is considered one of the godfathers of Alzheimer’s
research. He says that the human brain has the capacity to
live 120 years or longer with full mental vitality. “The
trick,” he says, “is to delay or prevent neurodegenerative
diseases such as Alzheimer’s, Parkinson’s, Huntington’s
and ALS [Amyotrophic Lateral Sclerosis].”
The Institute will be part
of the 61-acre Union Square development, and is being designed
by Frank Gehry, named by Time Magazine as the world’s
greatest living architect. Frank’s past projects include
the Guggenheim Museum in Bilbao, Spain; the Walt Disney Concert
Hall in downtown Los Angeles; the Dancing House “Fred
and Ginger” in Prague, Czech Republic; and the Experience
Music Project in Seattle.
Founder
Larry Ruvo says that LRBI will have a “tremendous impact”
on Las Vegas Real Estate. “Not only will the Institute
bring top-quality physicians and researchers to work with
Dr. Khachaturian, but it will also bring first-time visitors
who seek treatment or who just want to see Frank Gehry’s
building.” Larry believes that the increased economic
activity will “raise property values, help city pride,
and put Las Vegas on the map as a mature metropolitan area.
You can’t do that without a world-class medical community.”
Frank Gehry was initially
hesitant to help with the project. Larry explains, “I
believed the center needed a marketing tool to attract the
best physicians. That’s when I thought of Frank Gehry.
The mayor [Oscar Goodman] and I met with Frank. His opening
line was ‘I’m not building a building in Las Vegas.
I’ve already turned down other offers. I’m not
interested.’”
However, after a two-hour
conversation Larry and Frank found common ground. “It
turns out,” says Larry, “Frank has a history of
supporting Huntington’s [research]. Once Frank understood
how our project will help people with Huntington’s,
he signed on.”
The
main building, the 61,000-square-foot Gehry-Ruvo Building,
will incorporate Frank Gehry's signature contorted steel.
The office section resembles a series of stacked plaster and
glass blocks. In addition to the 39,000 square feet allotted
to clinical care, space will also be apportioned for an activities
center, a restaurant, and an interactive learning space called
the Museum of the Mind. Groundbreaking took place on February
9, 2007, and completion is expected in late 2008.
Larry named the Institute
after his father, Lou Ruvo, who was diagnosed with Alzheimer’s
and died in 1994. Larry cites his father as his closest friend.
“My father taught me that you always have to give back
to your community and help others.”
Lou
Ruvo trained at the Las Vegas Army Air Field, now Nellis Air
Force Base. After his army training, Lou and his family stayed
in Las Vegas and watched the city grow. Lou, along with Larry’s
mother Angie, opened the popular Venetian pizzeria, first
on Fremont Street and later on Sahara. Larry says that his
father “felt like he had to help newcomers get a stake
in the city. We were a pioneer family in Las Vegas, and we
wanted to help other families settle here.”
In 1969 Larry began working
for Wynn Distribution and quickly rose to management level.
When the company was sold to Southern Wine & Spirits,
Larry became the Senior Managing Director. As a wine executive,
Larry followed his father’s example by providing jobs
to the community. He also contributed enormous sums to charity,
and his endeavors have culminated in the Lou Ruvo Brain Institute.
LRBI’s mission is
to conquer Alzheimer’s, Parkinson’s, Huntington’s,
ALS, and other chronic brain disorders. Such a conquest includes
developing new techniques to prevent, to detect, to treat,
and eventually to cure dementia. The result will be to enhance
the quality of life for older Nevadans.
Larry says that Nevadans
will soon have improved access to Alzheimer’s specialists.
“Sadly, it’s now a three- to four-month wait to
see an Alzheimer’s specialist in Las Vegas,” he
says. “We’re going to change that.”
In
addition to clinical services, LRBI will also provide research,
education, and public policy “think tank” facilities.
Larry admits to being awed
by the scope of the project. He says, “What started
as a treatment facility has grown beyond imagination”
thanks to a partnership between the private and public sectors.
“The governor mentioned us in two State of the State
addresses and the legislature is helping us move forward.
When the world’s leading expert on Alzheimer’s
[Zaven Khachaturian] moved from Washington to Nevada, it was
a huge stamp of approval.”
Dr. Khachaturian says that
improving the prevention, delay, and treatment of Alzheimer’s
will improve the vitality of millions of Americans. He says
that nearly five million people nationwide are afflicted with
some form of dementia. He warns that the disease will become
even more prevalent as the baby boomers age. “If current
trends continue, the number of people at risk will double
in 20 years.”
The disease affects not
only patients, but also 10 million family care providers.
Dr. Khachaturian says that the nationwide financial burden
of caring for patients with dementia is “conservatively
estimated to exceed $100 billion per year.” He hopes
to ease that burden by detecting and treating dementia before
the symptoms become apparent. His goal is to “delay
the onset of disability until one hour before death”
by discovering concrete warning signs of Alzheimer’s
and other brain diseases.
In order to delay the onset
of symptoms, society’s understanding of dementia must
change. Most people currently think of Alzheimer’s as
a set of symptoms. Dr. Khachaturian says that the disease
is really biological. He explains “The disease begins
when [brain cells] become less efficient in communicating
with each other. This can happen when a patient is in his
20s or 30s.” Although the disease begins early in life,
the symptoms only appear later. “If we can understand
the biology of the disease instead of just treating the symptoms,
then we can delay the onset.”
Currently, the primary
known risk factors are age and family history. Dr. Khachaturian
plans to expand the list by recruiting thousands of baby boomers
for annual checkups for a period of 10-15 years. By recruiting
such a large sample for a long period of time, the research
team will develop a profile of Alzheimer’s patients
in the years leading up to disability. “We want to determine
what environmental, lifestyle and genetic markers can be used
as predictors.”
Eventually, Dr. Khachaturian
hopes to develop techniques of predicting Alzheimer’s
in the same way that mammography predicts breast cancer and
blood tests predict prostate cancer. He wants to take care
“not only of patients, but also of people at risk.”
Ultimately, he wants to
“find the mechanism by which nerve cells regenerate.
Then we can help the brain repair itself.” The result
will be “to keep people functioning normally for as
long as possible.”
Dr. Khachaturian says that
the life expectancy for baby boomers is between 95 and 100,
which includes 35 years of expected disability. “The
good news,” he says, “is that if you can delay
the onset of dementia symptoms by five years, then you can
cut the number of dementia cases in half,” which would
dramatically reduce the burden to society.
According to Dr. Khachaturian,
individuals who keep their bodies and minds active are less
likely to experience symptoms of dementia. “Exercise
your body,” he says. “Also, engage in creative
activities, learn a new language, and learn new skills.”
He adds that people with challenging occupations tend to get
the disease much later than others. Dr. Khachaturian’s
expertise on Alzheimer’s is unquestionable. His unified
theory on brain aging is the basis for Alzheimer’s treatment
worldwide. Once his theory was in place and tested, he worked
closely with the federal government to shape public health
policy and to ensure continued funding for brain aging research.
He coordinated all the Alzheimer’s research programs
at the National Institute of Health.
Dr.
Khachaturian’s résumé is expansive. In
addition to being the senior science advisor to the Alzheimer’s
Association, he is also the editor in chief of Alzheimer’s
Dementia: Journal of the Alzheimer’s Association, and
an adjunct professor of psychiatry and neuroscience at Johns
Hopkins University School of Medicine. He is a former director
of the Alzheimer’s Association Reagan Research Institute,
as well as a former director of the Office of Alzheimer’s
Disease Research at the National Institute on Aging.
Dr. Khachaturian says that
he is “thrilled to be working with the Lou Ruvo Brain
Institute.” Thanks to the generosity and dedication
of Larry Ruvo and a tremendous Board of Directors (listed
below) who are dedicated to finding a cure for these diseases,
the Institute will not only bring the world’s top experts
on brain aging to Las Vegas, but will also occupy a Frank
Gehry landmark building. Most importantly, the Institute will
create techniques to help people live with full vitality to
age 100 and beyond.
Mouse over any image to pause.
To read more about
the behind-the-scenes process of putting this article together,
please visit the
Letter From the Publisher.
|